A repetition of ovarian cancer It means that the disease has returned after you have been to recession or has been declared without diseases. While survival rates for people with repetitive ovarian cancer is currently about 3 out of 10, knowing your risks; supportive For yourself and active participation in your treatment and care can improve your outcome and prospects.
We talked to Blair McNamara, MD, a Gynecological Oncologist at the Yale University Medical School and a member of the Healthywomen Women’s Health Counseling Council on repetitive ovarian cancer and evolving treatment options.
How likely is it to repeat ovarian cancer?
The repetition of ovarian cancer is dependent on the stage of tumor in diagnosis, age and factors that tell us how aggressive the cancer is – the grade or histology. Most high quality ovarian cancer will be diagnosed with Stage 3 or Stage 4. More than 7 of 10 of these patients will experience repeating their disease in the first five years.
Read: What do you need to know about ovarian cancer >>
How is repeated ovarian cancer treated?
Repetitive ovarian cancer can sometimes be treated surgically if you have a period without six months or greater illness and if the disease is not widespread. Otherwise, and even after surgery, he is treated with repeated ovarian cancer chemotherapy.
What does the platinum resistant cancer mean?
Platina -resistant ovarian cancer means that the patient’s cancer has returned within six months of the completion of chemotherapy that included a platinum factor. Usually the agent is carboplatiinewhich works by preventing cancer cells from repairing or copying themselves.
Is the treatment different for platinum resistant to cancer?
Yes. In ovarian -resistant ovarian cancer, surgery is usually not taken into account and carboplatin treatment is not available. There are many other chemotherapy that can be used to treat ovarian cancer resistant to platinum and many of them are younger, targeted treatments. We used to tell patients that chemotherapy is much less likely to function when they have a disease -resistant disease. However, this is no longer the case with these newer treatments and treatment depends on the particular circumstance of a patient.
What are the biomarkers and biomarkers associated with cancer and ovarian repetition?
Biomarkers They are measurable chemicals in the body that can indicate the presence or progression of ovarian cancer, as well as its response to treatment. A blood test for CA-125 is often used in patients with ovarian cancer, as it can help oncologists determine what your response to chemotherapy will be and detect the recurrence of ovarian cancer. Tumors themselves can have different biomarkers recognized after initial surgery. These biomarkers can affect treatment for both the initial and repeated ovarian cancer.
How do they affect the results of biomarkers?
With new treatments for ovarian cancer resistant to Platinum in development and approved by the Federal Medicines (FDA), some tumor biomarkers suggest that a patient’s cancer will respond to a targeted chemotherapy. These targeted treatments are becoming more and more common and oncologists will determine which treatments you can have based on your biology of your tumor. For example, if they have tumors counter -defense deficiencyor HRD, patients may be eligible for certain oral maintenance options to prevent cancer from returning.
What factors should you consider when you weigh your treatment options?
The first thing your provider will consider in defining your treatment options is the nature of your cancer. For example, the stage, the degree, the location and the information of biomarkers available to you. When you make decisions on the treatment plan, you should consider how well tolerable chemotherapy during your initial treatment and discuss changes in your chemotherapy based on how well you have tolerate the initial treatment. Be sure to think of any other health issues you have and which activities are most important to you so you can prioritize them and discuss with your oncologist if the side effects of treatment can prevent the things you love. You may also want to consider participating in a clinical trial that could make you new treatments.
This educational resource was created with support from Daiichi Sankyo.
By the articles of your site
Related articles around the web
